Nipt denied as duplicate or overlapping therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for nipt are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denied NIPT as Duplicate Therapy

A duplicate-therapy denial means UHC's system flagged that a similar or equivalent test has already been ordered, processed, or billed within a defined look-back window — or that another prenatal screening test on file is considered to serve the same clinical purpose. For non-invasive prenatal testing (NIPT), this most often arises when a conventional aneuploidy screen (such as first-trimester or quad-screen serology) was already completed, or when NIPT was ordered more than once during the same pregnancy.

This denial is commonly appealable because NIPT and serum-based screens are clinically distinct modalities with different sensitivity and specificity profiles. They are not interchangeable in all clinical scenarios, and for certain high-risk indications the ordering clinician may have sound medical reasons for adding NIPT even after a prior screen. Document exactly why the prior test did not meet the clinical need.

## Federal Appeal Framework

Because UHC administers both fully insured and self-funded ERISA plans, your rights depend on your plan type:

• ACA §2719 / PPACA external review applies to most non-grandfathered fully insured plans. After exhausting internal appeals you have roughly four months (check your denial letter for the exact deadline) to request an independent external review.
• ERISA §503 full-and-fair review governs self-funded employer plans. You must exhaust the internal appeal first; external review access then depends on the plan document.
• Expedited review is available when standard timelines would seriously jeopardize your health or pregnancy — ask for it explicitly if your gestational window is closing.

## Appeal Process and Timeline

1. Request the full denial reason and the applicable UHC coverage policy in writing (you are entitled to both at no cost). 2. File a Level 1 internal appeal, typically within 180 days of the denial notice — confirm the deadline on your Explanation of Benefits. 3. If the Level 1 appeal is denied, file a Level 2 internal appeal if your plan offers one. 4. After exhausting internal appeals, request independent external review within the window stated in the final denial.

## Documentation to Gather

• Pregnancy and risk history: documentation establishing gestational age and any clinical risk factors recognized in current professional society guidance (consult the applicable ACOG/SMFM guideline for the current list of indications).
• Prior-test record: the exact test name, date, result, and ordering rationale for any prior screen UHC cited as the duplicate, plus a clear explanation of why it did not resolve the clinical question.
• Prescriber letter: a detailed medical-necessity letter from the ordering clinician explaining why NIPT is clinically distinct from and not redundant with the prior test, citing the specific clinical concern driving the order.
• Criteria mapping: pull the exact coverage criteria from UHC's published NIPT coverage policy and your plan's Summary Plan Description. For each criterion, document the chart fact that satisfies it.

## Criteria-Mapping Structure

Create a side-by-side table: left column lists each requirement verbatim from UHC's policy; right column cites the exact chart entry, date, and clinical note that satisfies it. Address the duplicate-therapy criterion directly by naming the prior test and explaining in clinical terms why the two tests are not equivalent for this patient's situation.